Announcements Trials
Browse Landscape

Phase

Phase NA 9Phase 2 4Phase 3 3Phase EARLY_PHASE1 2Phase 4 1Phase 1/2 1Phase 1 1

Status

Withdrawn 1Unknown 1Recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Venous Thrombosis 1Respiration Disorders 1Pulmonary Embolism 1Lung Diseases 1

Interventions

Metformin 16Cyclophosphamide 15Drug Therapy 14Dexamethasone 14Cisplatin 14Cytarabine 11Gemcitabine 10Radiotherapy 9Carboplatin 9Vincristine 8Paclitaxel 8Oxaliplatin 8Idarubicin 8Etoposide 8Docetaxel 8ulipristal acetate 7icotinib 7Sodium Chloride 7Methotrexate 7Fluorouracil 7Dexmedetomidine 7entecavir 6Thalidomide 6Surgical Procedures, Operative 6Sorafenib 6Pemetrexed 6Leuprolide 6Granulocyte Colony-Stimulating Factor 6Epirubicin 6Doxorubicin 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Unknown × Fluorodeoxyglucose F18 × Clear all
NCT03937583 2021-12-09

SOME-RIETE

Fundación Pública Andaluza para la gestión de la Investigación en Sevilla

Phase 4 Unknown
650 enrolled

Lung Diseases, Pulmonary Embolism, Respiration Disorders, Venous Thrombosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡